Background: : Hypertension is associated with poor outcome in patients with Coronavirus Disease-2019 (COVID-19). Several pro-inflammatory markers, such as Absolute Lymphocyte Count (ALC), Neutrophil-to-Lymphocyte Ratio (NLCR), Monocyte-to-Lymphocyte Ratio (MLCR), C-Reactive Protein (CRP), Procalcitonin (PCT), and Ferritin are associated with poor outcome in COVID-19. Pro-inflammatory markers in COVID-19 patients with hypertension is rarely described. Objective: : We aimed to explore several pro-inflammatory markers in COVID-19 patients with hypertension. Methods: We retrospectively analysed confirmed COVID-19 patients between March 1 and August 31, 2020 from Hasan Sadikin General Hospital Bandung. Data were obtained from patient's medical records. Patients with history of hypertension before admission were included in hypertension group. Patients with systolic blood pressure (BP) above 140 mmHg and/or diastolic BP above 90 mmHg on admission, were considered as uncontrolled hypertension. The analysis of data correlation was done using the Pearson correlation, alternative Rank Spearman correlation for non-normal distribution. Results: : We found 140 patients, in which 40 patients were included in hypertension group. NLCR (5.29 vs. 2.92, p = 0.002), MLCR (0.47 vs 0.31, p = 0.001), and CRP (5.62 vs 0.87, p = 0.004) were significantly higher in COVID-19 patients with hypertension. Meanwhile, ALC was found to be lower (1233.9 vs. 1533.9, p = 0.009). PCT (0.05 vs. 0.02, p = 0.079) and ferritin (329.3 vs 224.1, p = 0.073) were higher, but not statistically significant. There was no difference of NLCR, MLCR, CRP, ALC, PCT, and ferritin level between uncontrolled and controlled hypertension group. Conclusion: : COVID-19 patients with hypertension have higher pro-inflammatory markers.